DNAprint Genomics (DNAG)

[Blue Juggernaut]

Just got in from lots of yard work (my back is killing me) and read some of the best posts that I've seen on this board for sometime!

I, like many, have voted No on the R/S. Current funding for this company is fine for the short term. Releasing more shares into the market place (as needed) is a MUCH better option due to the FACT that the pps is so low. The only time I will ever vote for a r/s for this company or any other company is to get on an exchange or to get to a level (~>5.00) where more instituational investors look at you. As I have said before, for DNAP to get on a major exchange the r/s would have to get the price to 3 or 4 (depending on the exchange) due to minimum bid requirements and as of right now the minimum income requirements are too high for DNAP (this is a fact). My reasons are sound and factual to oppose the r/s. For those that are considering voting yes, please do some DD and ask the question WHY does the company want a r/s when it can not get us on an exchange. Please review this matter closely.

Good luck and God bless to all,
Big Blue (DNAP Long-Investor)